Blood Test May Detect Leukemia Risk
A new study reveals that a simple blood test using single-cell sequencing of rare stem cells can detect early signs of leukemia.
A new study reveals that a simple blood test using single-cell sequencing of rare stem cells can detect early signs of leukemia.
Datar Cancer Genetics introduced a blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD.
A study reveals that while diagnostic accuracy in genetic testing is consistent across racial groups, access disparities persist.
GeneDx announced enhancements to its whole genome sequencing services, all aimed at accelerating diagnoses and improving health outcomes.
Read MoreBaylor Genetics and Baylor College of Medicine have launched the Medical Genetics Multi-Omics Laboratory to innovate genetic testing.
Read MoreThe Unlock Behind the Seizure program aims to provide accessible and affordable genetic testing for pediatric epilepsy patients.
Read MoreWhole genome sequencing has improved care for some children with cancer in England and can potentially replace multiple standard tests.
Read MoreA new genotyping test using cerebrospinal fluid can rapidly diagnose brain cancers, reducing the need for invasive biopsies.
Read MoreFoundation Medicine launched a tissue-based RNA sequencing test in the U.S. for the detection of cancer-related fusions across 318 genes.Â
Read MoreJona announced a new distribution partnership where practitioners can order Jona kits, the company’s AI-powered gut microbiome profile test.
Read MoreResearchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read MoreThe collaboration seeks to demonstrate the value of WGS as a first-line genetic test for postnatal diagnosis of developmental delay disorders.
Read MoreResearchers developed a platform for integrating DNA and RNA data from single-cell sequencing with improved speed and precision.
Read MoreResearchers analyzed data from children who suffered from syndromic conditions and found a high incidence of overlapping genetic alterations.
Read MoreThe new suite of high-quality adapters, universal blockers, and library amplification primer mixes are designed for the AVITI System.
Read MoreThe system features full 24/7 run automation, flexibility for smaller and faster runs, high accuracy for germline applications, and more.
Read MoreFindings from NGS suggest that revising cancer care guidelines could allow many more patients to benefit from immunotherapy treatment.
Read MoreGenomenon, a genomic intelligence company, has launched Genomenon Curate-Pro, a rapid on-demand...
Read More